NOVAVAX INC (NVAX)
Biological Products, (No Diagnostic Substances) · Healthcare · $8.5B
Intrinsic Value (Consensus)
$38.33
Current Price
$51.60
Margin of Safety
-25.7%
25.7% Above Intrinsic Value
Value: $38
Price: $52
Valuation Model Estimates
Current Price: $51.60
DCF (Discounted Cash Flow)
Not applicable
—
Graham Number
Not applicable
—
Earnings Power Value
$25.05
Relative Value (P/E)
$51.60
Dividend Discount Model
Not applicable
—
Consensus Value
$38.33
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Key Financials
- EPS (TTM)
- $2.58
- EPS (Forward)
- $2.71
- Book Value
- $-0.78
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- N/A
- Debt/Equity
- —
- Revenue Growth
- 64.7%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Data last updated: 2026-06-12
Source: Yahoo Finance